Dana Farber Cancer Institute Dept.of DFCI

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Non-Hodgkin Lymphoma

Studies at this site

• Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients — Completed